share_log

IO Biotech Analyst Ratings

Benzinga ·  Aug 15, 2023 08:59
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/15/2023 264.58% Morgan Stanley $11 → $7 Maintains Overweight
08/11/2023 316.67% HC Wainwright & Co. $11 → $8 Reiterates Buy → Buy
03/15/2023 420.83% HC Wainwright & Co. → $10 Reiterates → Buy
01/24/2023 472.92% Morgan Stanley $15 → $11 Maintains Overweight
11/21/2022 420.83% HC Wainwright & Co. → $10 Initiates Coverage On → Buy
11/30/2021 993.75% Morgan Stanley → $21 Initiates Coverage On → Overweight
11/30/2021 Cowen & Co. Initiates Coverage On → Outperform
11/30/2021 941.67% Jefferies → $20 Initiates Coverage On → Buy

What is the target price for IO Biotech (IOBT)?

The latest price target for IO Biotech (NASDAQ: IOBT) was reported by Morgan Stanley on August 15, 2023. The analyst firm set a price target for $7.00 expecting IOBT to rise to within 12 months (a possible 264.58% upside). 5 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for IO Biotech (IOBT)?

The latest analyst rating for IO Biotech (NASDAQ: IOBT) was provided by Morgan Stanley, and IO Biotech maintained their overweight rating.

When is the next analyst rating going to be posted or updated for IO Biotech (IOBT)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of IO Biotech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for IO Biotech was filed on August 15, 2023 so you should expect the next rating to be made available sometime around August 15, 2024.

Is the Analyst Rating IO Biotech (IOBT) correct?

While ratings are subjective and will change, the latest IO Biotech (IOBT) rating was a maintained with a price target of $11.00 to $7.00. The current price IO Biotech (IOBT) is trading at is $1.92, which is out of the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment